Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @cotahealthcare
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @cotahealthcare
-
Prikvačeni tweet
Novel sources & growing volumes of data are changing the way drugs are developed, evaluated & brought to market. In the spirit of collaboration, COTA invited our partners from
@pfizer &@bmsnews to share their unique perspectives as early adopters of#RWE: https://bit.ly/36THwrB pic.twitter.com/8QrV2ZfzI7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@bmsnews is leading the race in the development of#MultipleMyeloma drugs, says a new@medcitynews piece. Learn more about the company's anti-BCMA drugs & new therapies coming down the pipeline: https://bit.ly/38ccUDb pic.twitter.com/FW4LnQSgpF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
COTA, Inc. proslijedio/la je Tweet
What’s it like to be rejected from a clinical trial? “The feeling like we’re able to fight, along with that hope — we felt like that was swept out from under us. And let’s face it: With Huntington’s, it’s a hopeless disease.” By
@DrewQJosephhttps://www.statnews.com/2019/12/04/a-clinical-trial-for-huntingtons-opens-the-door-to-hope-for-some-patients-but-only-so-many-can-get-in/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
COTA, Inc. proslijedio/la je Tweet
The two Q&As from this story are open access, too. Jeff Allen (
@CancerResrch): https://cancerletter.com/articles/20191122_2/ … & all ten "frenemy" health care research organizations: https://cancerletter.com/articles/20191122_3/ …pic.twitter.com/BJyuxBz0Nj
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, COTA is recognizing
#WorldCancerDay
– to raise awareness about prevention, detection & treatment. Since our beginning, COTA has been tirelessly working to improve the lives of cancer patients, and we will continue to do so by helping to bring clarity to #CancerCare.pic.twitter.com/fpntPD3awaHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At
#ASH19,@Virajn, COTA’s VP of Life Sciences, spoke with@AJMC_Journal on the growing understanding & acceptance of#RWD and how it is used in#clinical research. Hear his insight below as it relates to clinical trials & recent initiatives: https://bit.ly/39awxLY pic.twitter.com/rAh89LuuQb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In a joint effort with
@ASH_hematology,@LLSusa is expanding access to#clinicaltrial navigation & support tools to make it easier for patients to enroll and maintain participation in clinical trials:https://bit.ly/37D6EnGHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With no formal standards for what makes real-world evidence "regulatory grade,"
@PharmaPhorum looks at if and how this information can be used in the#regulatory decision making process: https://bit.ly/2tFARUb#RWEHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
COTA, Inc. proslijedio/la je Tweet
Patient-Centered Pathways in the Community: Utilizing RWE, AI Toolshttps://www.journalofclinicalpathways.com/multimedia/patient-centered-pathways-community-utilizing-rwe-ai-tools …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A recent report from the ONC for HIT found that only 58% of recently diagnosed cancer
#patients were offered access to their online#EHR, and only 40% of#patients actually viewed their record: https://bit.ly/2Gu1ApG@EHRintelpic.twitter.com/fdFQDb4FJQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
COTA, Inc. proslijedio/la je Tweet
AI in clinical trials: Andrew Norden CMO
@ANordenMD@cotahealthcare and Tufia Haddad@MayoClinic unpack the issues and outline progress in using big data and#AI in#clinicaltrials for cancer http://bit.ly/2GpCkkj pic.twitter.com/bTzAdIB716
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
COTA, Inc. proslijedio/la je Tweet
Why big pharma sees a remedy in data and AIhttps://on.ft.com/2U3vCZr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#TBT – Did you hear COTA, Inc. was named as one of@FierceHealth's 2020 Fierce 15 Companies? Learn what makes us fierce below: https://bit.ly/2t5d3Jg#Fierce15pic.twitter.com/9q8dkTOrPo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
COTA, Inc. proslijedio/la je Tweet
Roche's digital partnerships flourish under live-and-let-live approachhttps://www.fiercepharma.com/marketing/roche-s-digital-collabs-flourish-under-live-and-let-live-approach …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Is all
#data created equal? A recent@STATnews article looks at the use of#RWE to support more efficient clinical trials.@DataHippie, who leads the Global Medical Epidemiology & Big Data Analysis group at@pfizer, spoke around their work to harness RWD:https://bit.ly/2tWoeEgHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
COTA, Inc. proslijedio/la je Tweet
“This is a big step forward in personalizing cancer treatment and ensuring better patient outcomes,” said Professor Lim Chwee Teck, Mechanobiology Institute, NUS Biomedical Engineering.
#PrecisionMedicinehttps://bit.ly/30sYCuzHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
COTA, Inc. proslijedio/la je Tweet
“Platform business models have been a force of disruption in many sectors, rapid digitalization of
#healthcare is affording us unprecedented opportunity to solve complex medical problems and improve lives of people on a global scale” JH#JPMHC20#JPM2020https://www.fiercehealthcare.com/hospitals-health-systems/jpm20-what-s-going-at-biggest-conference-healthcare …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At
#ASH19, researchers presented a post-marketing study of tisagenlecleucel in the real-world setting. As they found real-world efficacy & safety was comparable to the JULIET trial, how could earlier use of#RWE transform clinical research? https://bit.ly/2REno77@JournalofCPpic.twitter.com/8PZW4AyjYc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
COTA, Inc. proslijedio/la je Tweet
Many cancer patients struggle with out-of-pocket cancer care expenses, with costs reaching nearly $150 billion nationally per year.
#healthcarehttp://ow.ly/GxbG30q9sqZHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As technology becomes more advanced in
#clinicalresearch, AMIA offers guidance to the NIH & FDA on#data sharing and how to regulate clinical decision support software: https://bit.ly/2tJXoPA@HDMmagazineHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.